Skip to main content
OpenTrials
Completed

NCT Number: NCT03626961

The Role of NEWS on Intensive Care Discharges

To determine the ability of the NEWS at tertiary intensive care unit discharges to predict the development of clinical deterioration.

To determine a cut-off value for NEWS score for early readmission

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intensive Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hitit university

Çorum, 19100, Turkey (Türkiye)

About this study

The Nationaly Early Warning Score (NEWS) is a single score based on the measurement of vital signs and inspired gases by the patient. A higher NEWS indicates severity of illness and risk of adverse outcomes. The use of NEWS values to select the appropriate patients for tertiary ICU discharges has not been tested. Our aim is to test the value of NEWS on discharges tertiary ICU.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older than 18 years old
  • Stay higher than 48 hours

Exclusion criteria

  • Under 18 years old
  • Stay lower than 48 hours
  • Intoxication
  • Exitus

Treatment and study plan

readmission

Other

Readmission after 48 hours

discharge

Other

Discharge

Primary outcomes

  1. Readmission rate

    Time frame: 48 hours

    Clinical deterioration within 48 hours after ICU transfer

Sponsors and collaborators

Lead sponsor

Hitit University

Other

Registry information

Official study title

The Role of NEWS on Tertiary Intensive Care Discharges

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Aug 13, 2018
Registry last updated
Aug 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.